Recruiting

Efficacy and Safety of LT3001 on Treating the Acute Ischemic Stroke

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(28 sites)

China

Beijing Luhe Hospital Capital Medical University, Beijing, Beijing Municipality

The First Affiliated Hospital of Jinan University, Guangzhou, Guangdong

Luoyang Third People's Hospital, Luoyang, He'nan

Harrison International Peace Hospital, Hengshui, Hebei

Daqing Oilfield General Hospital, Daqing, Heilongjiang

Zhongnan Hospital of Wuhan University, Wuhan, Hubei

The First Affiliated Hospital of Baotou Medical College, Baotou, Inner Mongolia

Inner Mongolia Baogang Hospital, Baotou, Inner Mongolia

Huai'an Second People's Hospital, Huai'an, Jiangsu

The Second Affiliated Hospital of Soochow University, Suzhou, Jiangsu

The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu

Pingxiang People's Hospital, Pingxiang, Jiangxi

The First Bethune Hospital of Jilin University, Changchun, Jilin

Beipiao Central Hospital, Chaoyang, Liaoning

Liaocheng People's Hospital, Liaocheng, Shandong

Yan'an University Xianyang Hospital, Xianyang, Shanxi

Xi'an Gaoxin Hospital, Xi’an, Shanxi

The Third Hospital of Mianyang, Mianyang, Sichuan

Zhejiang Hospital, Hangzhou, Zhejiang

Taizhou Municipal Hospital, Taizhou, Zhejiang

Taizhou First People's Hospital, Taizhou, Zhejiang

Beijing Tiantan Hospital, Capital Medical University, Beijing

Beijing Tsinghua Changgung Hospital, Beijing

Linfen Central Hospital, Linfen

Linfen People's Hospital, Linfen

Nanshi Hospital of Nanyang, Nanyang

Shanghai Pudong Hospital, Shanghai

Central People's Hospital of Zhanjiang, Zhanjiang